D. M. Brewer and . Schultze, Bizzozero (1882) and the discovery of the platelet, Br J Haematol, vol.133, pp.251-259, 1865.

S. Lindemann, B. Krämer, P. Seizer, and M. Gawaz, Platelets, inflammation, and atherosclerosis, J Thromb Haemost, pp.203-214, 2007.

B. Engelmann and S. Massberg, Thrombosis as an intravascular effector of innate immunity, Nat Rev Immunol, vol.13, pp.34-45, 2013.

L. J. Gay and B. Felding-habermann, Contribution of platelets to tumour metastasis, Nat Rev Cancer, vol.11, pp.123-157, 2011.

M. Holinstat, Normal platelet function, Cancer Metastasis Rev, vol.36, pp.195-203, 2017.

K. R. Machlus and J. E. Italiano, The incredible journey: from megakaryocyte development to platelet formation, J Cell Biol, vol.201, pp.785-96, 2013.

T. Gremmel, A. Frelinger, and A. Michelson, Platelet physiology, Semin Thromb Hemost, vol.42, pp.191-204, 2016.

C. B. Thompson, J. A. Jakubowski, P. G. Quinn, D. Deykin, and C. R. Valeri, Platelet size and age determine platelet function independently, Blood, vol.63, pp.1372-1377, 1984.

A. T. Sayit, P. H. Gunbey, and Y. Terzi, Is the mean platelet volume in patients with acute cholecystitis an inflammatory marker?, J Clin Diagn Res, vol.9, pp.5-7, 2015.

D. G. Menter, S. Kopetz, E. Hawk, A. K. Sood, J. M. Loree et al., Platelet "first responders" in wound response, cancer, and metastasis, Cancer Metastasis Rev, vol.36, pp.199-213, 2017.

N. M. Bambace and C. E. Holmes, The platelet contribution to cancer progression, J Thromb Haemost, vol.9, pp.237-286, 2011.

J. N. Thon and J. E. Italiano, Platelets: production, morphology and ultrastructure, Handb Exp Pharmacol, vol.210, pp.3-22, 2012.

O. Pagel, E. Walter, K. Jurk, and R. P. Zahedi, Taking the stock of granule cargo: platelet releasate proteomics, Platelets, vol.28, pp.119-147, 2017.

M. Z. Wojtukiewicz, E. Sierko, D. Hempel, S. C. Tucker, and K. V. Honn, Platelets and cancer angiogenesis nexus, Cancer Metastasis Rev, vol.36, pp.249-62, 2017.

E. De-candia, Mechanisms of platelet activation by thrombin: a short history, Thromb Res, vol.129, pp.250-256, 2012.

D. A. Morrow, E. Braunwald, M. P. Bonaca, S. F. Ameriso, A. J. Dalby et al., Vorapaxar in the secondary prevention of atherothrombotic events, N Engl J Med, vol.366, pp.1404-1417, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00793696

A. R. Hardy, M. L. Jones, S. J. Mundell, and A. W. Poole, Reciprocal cross-talk between P2Y1 and P2Y12 receptors at the level of calcium signaling in human platelets, Blood, vol.104, pp.1745-52, 2004.

A. M. Randi and M. A. Laffan, Von Willebrand factor and angiogenesis: basic and applied issues, J Thromb Haemost, vol.15, pp.13-20, 2017.

X. R. Xu, D. Zhang, B. E. Oswald, N. Carrim, X. Wang et al., Platelets are versatile cells: new discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond, Crit Rev Clin Lab Sci, vol.53, pp.409-439, 2016.

S. Gyobu, K. Ishihara, J. Suzuki, K. Segawa, and S. Nagata, Characterization of the scrambling domain of the TMEM16 family, Proc Natl Acad Sci, vol.114, pp.6274-6283, 2017.

M. Schlesinger, Role of platelets and platelet receptors in cancer metastasis, J Hematol Oncol, vol.11, p.125, 2018.

A. Varki, Trousseau's syndrome: multiple definitions and multiple mechanisms, Blood, vol.110, pp.1723-1732, 2007.

P. Ferroni, F. Martini, I. Portarena, I. Grenga, S. Riondino et al., An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients, Thromb Haemost, vol.105, pp.931-933, 2011.

E. Heinmöller, R. J. Weinel, H. H. Heidtmann, U. Salge, R. Seitz et al., Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines, J Cancer Res Clin Oncol, vol.122, pp.735-779, 1996.

E. Heinmöller, T. Schropp, O. Kisker, B. Simon, R. Seitz et al., Tumor cellinduced platelet aggregation in vitro by human pancreatic cancer cell lines

, Scand J Gastroenterol, vol.30, pp.1008-1024, 1995.

E. Pearlstein, P. L. Salk, G. Yogeeswaran, and S. Karpatkin, Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line, Proc Natl Acad Sci, vol.77, pp.4336-4345, 1980.

S. Mezouar, C. Frère, R. Darbousset, D. Mege, L. Crescence et al., Role of platelets in cancer and cancer-associated thrombosis: experimental and clinical evidences, Thromb Res, vol.139, pp.65-76, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01455290

M. A. Adesanya, A. Maraveyas, and L. A. Madden, PO-27 -Thrombin generation in pancreatic cancer and multiple myeloma with use of calibrated automated thrombography, J Thromb Haemost, vol.140, pp.1800-1814, 2005.

D. G. Menter, S. C. Tucker, S. Kopetz, A. K. Sood, J. D. Crissman et al., Platelets and cancer: a casual or causal relationship: revisited, Cancer Metastasis Rev, vol.33, pp.231-69, 2014.

N. Li, Platelets in cancer metastasis: To help the "villain" to do evil, Int J Cancer, vol.138, pp.2078-87, 2016.

K. Suzuki-inoue, G. L. Fuller, A. García, J. A. Eble, S. Pöhlmann et al., A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2, Blood, vol.107, pp.542-551, 2006.

D. Lechner and A. Weltermann, Chemotherapy-induced thrombosis: a role for microparticles and tissue factor?, Semin Thromb Hemost, vol.34, pp.199-203, 2008.

S. Mezouar, D. Mege, R. Darbousset, D. Farge, P. Debourdeau et al., Involvement of platelet-derived microparticles in tumor progression and thrombosis, Semin Oncol, vol.41, pp.346-58, 2014.

G. M. Thomas, A. Brill, S. Mezouar, L. Crescence, M. Gallant et al., Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice, J Thromb Haemost, vol.13, pp.1310-1319, 2015.

B. Shao, M. G. Wahrenbrock, L. Yao, T. David, S. R. Coughlin et al., Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome, Blood, vol.118, pp.4015-4038, 2011.

N. Faraday, K. Schunke, S. Saleem, J. Fu, B. Wang et al., Cathepsin G-dependent modulation of platelet thrombus formation in vivo by blood neutrophils, PLoS ONE, vol.8, 2013.

L. Oleksowicz, N. Bhagwati, and M. Deleon-fernandez, Deficient activity of von Willebrand's factor-cleaving protease in patients with disseminated malignancies, Cancer Res, vol.59, pp.2244-50, 1999.

B. H. Koo, D. Oh, S. Y. Chung, N. K. Kim, S. Park et al., Deficiency of von Willebrand factor-cleaving protease activity in the plasma of malignant patients, Thromb Res, vol.105, pp.471-477, 2002.

S. Kumar, N. Rao, and R. Ge, Emerging roles of ADAMTSs in angiogenesis and cancer, Cancers, vol.4, pp.1252-99, 2012.

P. Patrignani and C. Patrono, Aspirin, platelet inhibition, and cancer prevention, Platelets, vol.29, pp.779-85, 2018.

M. Dovizio, A. Bruno, S. Tacconelli, and P. Patrignani, Mode of action of aspirin as a chemopreventive agent, Recent Results Cancer Res, vol.191, pp.39-65, 2013.

A. Bruno, M. Dovizio, S. Tacconelli, and P. Patrignani, Mechanisms of the antitumoural effects of aspirin in the gastrointestinal tract, Best Pract Res Clin Gastroenterol, vol.26, pp.1-13, 2012.

P. Guillem-llobat, M. Dovizio, A. Bruno, E. Ricciotti, V. Cufino et al., Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells, Oncotarget, vol.7, pp.32462-77, 2016.

P. Patrignani and C. Patrono, Aspirin and cancer, J Am Coll Cardiol, vol.68, pp.967-76, 2016.

S. Karpatkin, C. Ambrogio, and E. Pearlstein, The role of tumor-induced platelet aggregation, platelet adhesion and adhesive proteins in tumor metastasis, Prog Clin Biol Res, vol.283, pp.585-606, 1988.

S. Wang, Z. Li, and R. Xu, Human cancer and platelet interaction, a potential therapeutic target, Int J Mol Sci, vol.19, p.1246, 2018.

T. A. Waldmann, Cytokines in cancer immunotherapy, Cold Spring Harb Perspect Biol, vol.10, p.28472, 2018.

J. V. Michael, J. Wurtzel, G. F. Mao, A. K. Rao, M. A. Kolpakov et al., Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth, vol.130, pp.567-80, 2017.

K. Egan, N. Cooke, and D. Kenny, Living in shear: platelets protect cancer cells from shear induced damage, Clin Exp Metastasis, vol.31, pp.697-704, 2014.

N. E. Tsopanoglou and M. E. Maragoudakis, Role of thrombin in angiogenesis and tumor progression, Semin Thromb Hemost, vol.30, pp.63-72, 2004.

B. A. Kerr, N. P. Mccabe, W. Feng, and T. V. Byzova, Platelets govern premetastatic tumor communication to bone, Oncogene, vol.32, pp.4319-4343, 2013.

M. Labelle, S. Begum, and R. O. Hynes, Platelets guide the formation of early metastatic niches, Proc Natl Acad Sci, vol.111, pp.3053-61, 2014.

M. Rolli, E. Fransvea, J. Pilch, A. Saven, and B. Felding-habermann, Activated integrin v 3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells, Proc Natl Acad Sci, vol.100, pp.9482-9489, 2003.

D. Buergy, F. Wenz, C. Groden, and M. A. Brockmann, Tumor-platelet interaction in solid tumors, Int J Cancer, vol.130, pp.2747-60, 2012.

G. J. Gasic, T. B. Gasic, and C. C. Stewart, Antimetastatic effects associated with platelet reduction, Proc Natl Acad Sci, vol.61, pp.46-52, 1968.

B. Nieswandt, M. Hafner, B. Echtenacher, and D. N. Männel, Lysis of tumor cells by natural killer cells in mice is impeded by platelets, Cancer Res, vol.59, pp.1295-300, 1999.

T. Placke, M. Örgel, M. Schaller, G. Jung, H. G. Rammensee et al., Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells, Cancer Res, vol.72, pp.440-448, 2012.

P. S. Steeg, New insights into the tumor metastatic process revealed by gene expression profiling, Am J Pathol, vol.166, issue.10, pp.62348-62354, 2005.

W. H. Li, Y. Qiu, H. Q. Zhang, Y. Liu, J. F. You et al., P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells, Br J Cancer, vol.109, pp.1666-75, 2013.

P. Ballerini, M. Dovizio, A. Bruno, S. Tacconelli, and P. Patrignani, P2Y12 receptors in tumorigenesis and metastasis, Front Pharmacol, vol.9, p.66, 2018.

D. Schumacher, B. Strilic, K. K. Sivaraj, N. Wettschureck, and S. Offermanns, Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor, Cancer Cell, vol.24, pp.130-137, 2013.

V. Leoncikas, H. Wu, L. T. Ward, A. M. Kierzek, and N. J. Plant, Generation of 2,000 breast cancer metabolic landscapes reveals a poor prognosis group with active serotonin production, Sci Rep, vol.6, 2016.

J. S. Byun and K. Gardner, Wounds that will not heal: pervasive cellular reprogramming in cancer, Am J Pathol, vol.182, pp.1055-64, 2013.

P. Carmeliet and R. K. Jain, Angiogenesis in cancer and other diseases, Nature, vol.407, pp.249-57, 2000.

H. A. Goubran, T. Burnouf, M. Radosevic, and M. El-ekiaby, The platelet-cancer loop, Eur J Intern Med, vol.24, pp.393-400, 2013.

A. K. Olsson and J. Cedervall, The pro-inflammatory role of platelets in cancer, Platelets, vol.29, pp.569-73, 2018.

C. A. Gleissner, P. Von-hundelshausen, and K. Ley, Platelet chemokines in vascular disease, Arterioscler Thromb Vasc Biol, vol.28, pp.1920-1927, 2008.

X. Sun, G. Cheng, M. Hao, J. Zheng, X. Zhou et al., CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression, Cancer Metastasis Rev, vol.29, pp.709-731, 2010.

G. T. Brown, P. Narayanan, W. Li, R. L. Silverstein, and T. M. Mcintyre, Lipopolysaccharide stimulates platelets through an IL-1 autocrine loop, J Immunol, vol.191, pp.5196-203, 2013.

C. Neuzillet, A. Tijeras-raballand, R. Cohen, J. Cros, S. Faivre et al., Targeting the TGF? pathway for cancer therapy, Pharmacol Ther, vol.147, pp.22-31, 2015.

V. Brinkmann, U. Reichard, C. Goosmann, B. Fauler, Y. Uhlemann et al., Neutrophil extracellular traps kill bacteria, Science, vol.303, pp.1532-1537, 2004.

J. Cools-lartigue, J. Spicer, S. Najmeh, and L. Ferri, Neutrophil extracellular traps in cancer progression, Cell Mol Life Sci, vol.71, pp.4179-94, 2014.

A. S. Kimball, A. T. Obi, J. A. Diaz, and P. K. Henke, The emerging role of NETs in venous thrombosis and immunothrombosis, Front Immunol, vol.7, p.236, 2016.

S. K. Jorch and P. Kubes, An emerging role for neutrophil extracellular traps in noninfectious disease, Nat Med, vol.23, pp.279-87, 2017.

J. Cedervall, A. Hamidi, and A. Olsson, Platelets, NETs, and cancer. Thromb Res, vol.164, pp.148-52, 2018.

J. Etulain, K. Martinod, S. L. Wong, S. M. Cifuni, M. Schattner et al., P-selectin promotes neutrophil extracellular trap formation in mice, Blood, vol.126, pp.242-248, 2015.

T. A. Fuchs, A. Brill, D. Duerschmied, D. Schatzberg, M. Monestier et al., Extracellular DNA traps promote thrombosis, Proc Natl Acad Sci USA, vol.107, pp.15880-15885, 2010.

J. A. Diaz, T. A. Fuchs, T. O. Jackson, K. Hovinga, J. A. Lämmle et al., Plasma DNA is elevated in patients with deep vein thrombosis, J Vasc Surg Venous Lymphat Disord, vol.1, p.341, 2013.

M. Demers, D. S. Krause, D. Schatzberg, K. Martinod, J. R. Voorhees et al., Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis, Proc Natl Acad Sci, vol.109, pp.13076-81, 2012.

L. Erpenbeck and M. P. Schön, Neutrophil extracellular traps: protagonists of cancer progression? Oncogene, vol.36, pp.2483-90, 2017.